Placenta is Capable of Protecting the Male Fetus from Exposure to Environmental Bisphenol A

Embryo-fetal exposure to bisphenol A (BPA) could be related to poor male reproductive parameters in rodents, but this concept has not been convincingly confirmed in humans. We investigated the association of environmental BPA exposure of pregnant women with selected endocrine and anthropometric parameters of male newborns. We analyzed plasma BPA from pregnant mothers, umbilical cord, and placental tissues (n = 117/each group) by liquid chromatography and mass spectrometry. LH, FSH, AMH, TGF beta 2, inhibin B, and selected sex steroids were measured in cord plasma. The infant anthropometric parameters included anogenital distance, stretched penile length, head circumference, birthweight, and length. The median BPA concentrations in maternal and umbilical cord plasma, and in placental tissue were 19.0, 8.0, and 22.2 nmol/L, respectively, the levels thus being over twofold lower in the fetal circulation than in the mother or placenta. The BPA concentrations measured were 100-1000-fold lower than those demonstrated in animal experiments to have endocrine disrupting effects. Multivariable regression analysis indicated no significant correlations between the maternal/fetal/placental BPA concentrations and any of the hormone levels or anthropometric parameter measured. Plasma concentrations of BPA confirmed both maternal, placenta, and fetal exposure to environmental BPA, but the concentrations were orders of magnitude lower than those with documented endocrine disrupting activity. Moreover, the maternal/fetal concentration gradient as well as the lack of correlations of BPA levels with any major endocrine or anthropometric parameters measured in the newborns suggest a protective role for the placenta in reducing fetal exposure to the environmental BPA

Electrodegradation of Resorcinol on Pure and Catalyst-Modified Ni Foam Anodes, Studied under Alkaline and Neutral pH Conditions

This work reports on the kinetics of electrochemical degradation of the resorcinol molecule, examined on nickel foam-based electrodes in contact with 0.1 M NaOH and 0.5 M Na2SO4 supporting electrolytes. The electrooxidation of resorcinol was examined on as-received, as well as on Pd-modified, nickel foam catalyst materials, produced via spontaneous deposition of trace amounts of palladium element. Electrochemical (cyclic voltammetry and a.c. impedance) experiments were carried out by means of a three-compartment, pyrex glass electrochemical cell, whereas continuous resorcinol electrooxidation tests were conducted galvanostatically (or potentistatically) with a laboratory-size, single-cell electrolyzer unit. In addition, quantitative determination of resorcinol and its possible electrodegradation products was performed by means of instrumental HPLC: High-Performance Liquid Chromatography/MS: Mass Spectrometry methodology. Also, SEM (Scanning Electron Microscopy) and EDX (Energy Dispersive X-ray spectroscopy) techniques were employed for Ni foam (Pd-modified Ni foam) surface characterizations

The Influence of Solution pH on the Kinetics of Resorcinol Electrooxidation (Degradation) on Polycrystalline Platinum

Electrochemical oxidation of resorcinol on a polycrystalline platinum electrode was investigated in five different solutions, namely 0.5 and 0.1 M H2SO4, 0.5 M Na2SO4, 0.5 and 0.1 M NaOH. The rates of electrochemical degradation of resorcinol were determined based on the obtained reaction parameters, such as resistance, capacitance and current-density. The electrochemical analyses (cyclic voltammetry and a.c. impedance spectroscopy) were carried-out by means of a three-compartment, Pyrex glass cell. These results showed that the electrochemical oxidation of resorcinol is strongly pH-dependent. In addition, the energy dispersive X-ray (EDX) spectroscopy technique was employed for Pt electrode surface characterization. Additionally, the quantitative determination of resorcinol removal was performed by means of instrumental high-performance liquid chromatography/mass spectrometry (HPLC/MS) methodology

Polyphenol Extract from Evening Primrose (Oenothera paradoxa) Inhibits Invasion Properties of Human Malignant Pleural Mesothelioma Cells

Extracts from the defatted evening primrose (Oenothera paradoxa Hudziok) seeds are the source of a range of stable polyphenolic compounds, including ellagic acid, gallic acid, and catechin. Our studies evaluate, for the first time, the influence of evening primrose isopropanol extract (EPE) on malignant pleural mesothelioma (MPM) cells. MPM is rarely diagnosed, its high aggressiveness and frequently noted chemoresistance limit its treatment schemes and it is characterized by low prognostic features. Here, we demonstrate that EPE inhibited MPM growth in a dose-dependent manner in cells with increased invasion properties. Moreover, EPE treatment resulted in cell cycle arrest in the G2/M phase and increased apoptosis in invasive MPM cell lines. Additionally, EPE strongly limited invasion and MMP-7 secretion in MPM cancer cells. Our original data provide evidence about the potential anti-invasive effects of EPE in MPM therapy treatment

A Review of Factors Affecting Anthocyanin Bioavailability: Possible Implications for the Inter-Individual Variability

nthocyanins are dietary bioactive compounds showing a range of beneficial effects against cardiovascular, neurological, and eye conditions. However, there is, as for other bioactive compounds in food, a high inter and intra-individual variation in the response to anthocyanin intake that in many cases leads to contradictory results in human trials. This variability could be caused at two levels, one at the bioavailability level and the other at the effect and mechanisms of action. In this context, we have thoroughly reviewed the scientific literature on anthocyanins variability caused by variation in bioavailability. Based on the literature reviewed, we have concluded that the variability in anthocyanins bioavailability might be produced by the lack of homogeneity introduced at three different levels: food matrix and food processing, enzymes involved in anthocyanin metabolism and transport, and anthocyanin metabolizing gut microbiota. However, it should be noted that the literature on anthocyanins bioavailability considering inter or intra-individual variability is still very scarce, which makes it difficult to reach any firm conclusion on the main metabolizing enzymes or bacteria that would be responsible for the variability in anthocyanin bioavailability